by Viara Staneva | Apr 29, 2019 | news
Word came out just before the weekend (first at Endpoints) that GlaxoSmithKline is laying off R&D employees at both Stevenage (UK) and Upper Providence (US). Current leadership is re-organizing drug discovery efforts to put more emphasis on oncology,...
by Viara Staneva | Apr 25, 2019 | news
You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription ($200/year for individuals and $1,000/year for companies of every size): https://endpts.com/subscribeAlready a paid subscriber? Sign in to Endpoints...
by Viara Staneva | Apr 22, 2019 | news
CRISPR has been tested in US patients for the first time — but perhaps not in the manner you imagined. The University of Pennsylvania has led the way dosing two patients with relapsed cancers — one with multiple myeloma and one with sarcoma — with a T cell therapy in...
by Viara Staneva | Apr 10, 2019 | news
Pharma IQ spoke to Jeremy Schafer and Scott Marshall to find out their predictions. The manufacturing and clinical landscapes are set to see further change over the coming years. Pharma IQ spoke to Jeremy Schafer and Scott Marshall to find out their predictions....
by Viara Staneva | Apr 5, 2019 | news
You need a license to cut-and-paste this copyrighted news content. Use this link to purchase your paid subscription ($200/year for individuals and $1,000/year for companies of every size): https://endpts.com/subscribe Already a paid subscriber? Sign in to Endpoints...